MAYBAKER – MAYBAKER delivered an impressive performance in Q1:2022, as topline grew by 23.54%YoY to NGN3.34bn, bolstered by increased sales in the Pharmaceutical segment (+23.37% YoY). The beverage segment also expanded (+324.59% YoY) for the first time in five (5) quarters.
FIDSON – FIDSON sustained its double-digit growth rate in Q1:2022 as revenue surged by 61.23%YoY to NGN10.24bn from NGN6.32bn in Q1:2021. The firm witnessed significant revenue growth across all segments: Ethical (+75.95%YoY), Over-the-Counter (+29.86%YoY), Consumer Health Product (+542.05%YoY).
NEIMETH – NEIMETH’s performance remained unimpressive in the first half of its 2022 financial period (year-end is September) as its revenue declined by 23.12%YoY to NGN0.99bn from NGN1.28bn in H1:2021. Revenue from both the Pharmaceuticals segment (-6.57%YoY) and Animal Health segment (-88.16%YoY) declined in the period, reflective of the intense competition in the pharmaceutical market.
